Cargando…
High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer
It is generally accepted that early detection of breast cancer has great impact on patient survival, emphasizing the importance of early diagnosis. In a widely recognized model of breast cancer development, tumor cells progress through chronological and well defined stages. However, the molecular ba...
Autores principales: | Rennstam, Karin, Hedenfalk, Ingrid |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779477/ https://www.ncbi.nlm.nih.gov/pubmed/16895590 http://dx.doi.org/10.1186/bcr1528 |
Ejemplares similares
-
Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression
por: Stenström, Jenny, et al.
Publicado: (2021) -
Estrogen and progesterone receptor levels in nonneoplastic breast epithelium of breast cancer cases versus benign breast biopsy controls
por: Woolcott, Christy G, et al.
Publicado: (2008) -
The Landscape of Candidate Driver Genes Differs between Male and Female Breast Cancer
por: Johansson, Ida, et al.
Publicado: (2013) -
CD169(+) Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, T(regs) and a Worse Prognosis for Patients with Advanced Breast Cancer
por: Briem, Oscar, et al.
Publicado: (2023) -
Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies
por: Visscher, Daniel W., et al.
Publicado: (2017)